Becton, Dickinson and Company (0R19.L)
USD 167.54
(-4.69%)
USD 167.54
(-4.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.82 Billion USD | 4.08% |
| 2022 | 8.47 Billion USD | -1.78% |
| 2021 | 8.63 Billion USD | 26.96% |
| 2020 | 6.79 Billion USD | -9.34% |
| 2019 | 7.49 Billion USD | 3.15% |
| 2018 | 7.26 Billion USD | 22.33% |
| 2017 | 5.94 Billion USD | -0.82% |
| 2016 | 5.99 Billion USD | 20.11% |
| 2015 | 4.98 Billion USD | 15.97% |
| 2014 | 4.3 Billion USD | 3.12% |
| 2013 | 4.17 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.02 Billion USD | 19.17% |
| 2024 Q3 | 2.3 Billion USD | 0.13% |
| 2024 Q2 | 2.3 Billion USD | 13.67% |
| 2023 Q3 | 2.1 Billion USD | -6.04% |
| 2023 Q2 | 2.23 Billion USD | 4.78% |
| 2023 FY | 8.17 Billion USD | -3.62% |
| 2023 Q1 | 2.13 Billion USD | 2.75% |
| 2023 Q4 | 1.7 Billion USD | -19.0% |
| 2022 FY | 8.47 Billion USD | -1.78% |
| 2022 Q4 | 2.07 Billion USD | 0.44% |
| 2022 Q3 | 2.06 Billion USD | -10.33% |
| 2022 Q2 | 2.3 Billion USD | -4.87% |
| 2022 Q1 | 2.42 Billion USD | 5.26% |
| 2021 Q1 | 2.76 Billion USD | 10.24% |
| 2021 Q3 | 2.16 Billion USD | 18.74% |
| 2021 FY | 8.63 Billion USD | 26.96% |
| 2021 Q4 | 2.3 Billion USD | 6.52% |
| 2021 Q2 | 1.82 Billion USD | -34.2% |
| 2020 Q3 | 1.66 Billion USD | -15.78% |
| 2020 Q4 | 2.5 Billion USD | 51.14% |
| 2020 FY | 6.79 Billion USD | -9.34% |
| 2020 Q2 | 1.97 Billion USD | -0.35% |
| 2020 Q1 | 1.97 Billion USD | -12.71% |
| 2019 Q2 | 1.97 Billion USD | 0.05% |
| 2019 FY | 7.49 Billion USD | 3.15% |
| 2019 Q4 | 2.26 Billion USD | 9.26% |
| 2019 Q3 | 2.07 Billion USD | 5.07% |
| 2019 Q1 | 1.97 Billion USD | -8.28% |
| 2018 FY | 7.26 Billion USD | 22.33% |
| 2018 Q4 | 2.15 Billion USD | 3.81% |
| 2018 Q3 | 2.07 Billion USD | 2.17% |
| 2018 Q2 | 2.02 Billion USD | 30.59% |
| 2018 Q1 | 1.55 Billion USD | -0.06% |
| 2017 Q4 | 1.55 Billion USD | 3.39% |
| 2017 FY | 5.94 Billion USD | -0.82% |
| 2017 Q1 | 1.45 Billion USD | -6.44% |
| 2017 Q2 | 1.43 Billion USD | -1.38% |
| 2017 Q3 | 1.5 Billion USD | 4.96% |
| 2016 Q2 | 1.48 Billion USD | 5.33% |
| 2016 Q3 | 1.54 Billion USD | 4.32% |
| 2016 Q1 | 1.4 Billion USD | -2.36% |
| 2016 Q4 | 1.55 Billion USD | 0.32% |
| 2016 FY | 5.99 Billion USD | 20.11% |
| 2015 Q2 | 1.04 Billion USD | 0.1% |
| 2015 Q1 | 1.04 Billion USD | -5.6% |
| 2015 FY | 4.98 Billion USD | 15.97% |
| 2015 Q4 | 1.44 Billion USD | -0.89% |
| 2015 Q3 | 1.45 Billion USD | 39.1% |
| 2014 Q3 | 1.11 Billion USD | 5.51% |
| 2014 Q2 | 1.05 Billion USD | 1.74% |
| 2014 Q1 | 1.03 Billion USD | -4.78% |
| 2014 FY | 4.3 Billion USD | 3.12% |
| 2014 Q4 | 1.1 Billion USD | -0.36% |
| 2013 Q2 | 1.01 Billion USD | 1.19% |
| 2013 Q1 | 1 Billion USD | 0.0% |
| 2013 Q4 | 1.08 Billion USD | 2.55% |
| 2013 FY | 4.17 Billion USD | 0.0% |
| 2013 Q3 | 1.06 Billion USD | 4.13% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -4273.343% |
| Accuray Incorporated | 143.12 Million USD | -6064.714% |
| Align Technology, Inc. | 2.72 Billion USD | -224.356% |
| Elevance Health Inc. | 47.01 Billion USD | 81.232% |
| AxoGen, Inc. | 127.87 Million USD | -6799.761% |
| Boston Scientific Corporation | 9.84 Billion USD | 10.417% |
| CVS Health Corporation | 54.43 Billion USD | 83.79% |
| Cardinal Health, Inc. | 7.41 Billion USD | -19.005% |
| Centene Corporation | 153.99 Billion USD | 94.271% |
| DaVita Inc. | 3.82 Billion USD | -130.943% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 83.977% |
| Hologic, Inc. | 2.23 Billion USD | -294.271% |
| Humana Inc. | 106.44 Billion USD | 91.711% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -302.882% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -162.207% |
| Masimo Corporation | 1 Billion USD | -779.223% |
| McKesson Corporation | 12.58 Billion USD | 29.887% |
| Patterson Companies, Inc. | 1.38 Billion USD | -539.236% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -197.974% |
| ResMed Inc. | 2.6 Billion USD | -238.204% |
| Henry Schein, Inc. | 3.65 Billion USD | -141.66% |
| Teladoc Health, Inc. | 1.84 Billion USD | -378.89% |
| Universal Health Services, Inc. | 1.17 Billion USD | -650.65% |
| Veeva Systems Inc. | 1.68 Billion USD | -423.191% |
| Baxter International Inc. | 4.97 Billion USD | -77.347% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | -86.552% |
| Danaher Corporation | 14.12 Billion USD | 37.554% |
| Stryker Corporation | 13.05 Billion USD | 32.432% |
| Medtronic plc | 21.27 Billion USD | 58.525% |